Burrill health fund tops $500m with eye on exit alternatives, new markets
This article was originally published in Scrip
Executive Summary
Burrill & Company has added nearly $200 million to its fourth venture capital fund, giving the life science-focused financial services firm $505 million to invest in therapeutics, diagnostics, medical devices, health care services and digital health.